Moreover, to investigate the relationship between LAPTM4B genotypes and cancer clinical parameters, we analysed the distribution of histopathologic differentiation and classification of TNM and found that the LAPTM4B polymorphism was associated with histopathologic differentiation (heterozygote and dominant models). The gene discussed is LAPTM4B; the disease is cancer.